Regenerative medicine: New opportunities for developing countries

There has been a major shift in burden of disease in developing countries. Although traditionally associated with industrialised nations, epidemic levels of non-communicable diseases, such as diabetes, cardiovascular diseases and cancer, now threaten the developing world and are straining health systems that are still struggling with persisting levels of infectious disease. Developing countries need innovative and affordable ways of dealing with this 'double burden'. The emerging field of regenerative medicine may provide new opportunities to address these health needs if employed with the goal of improving global health equity. Several developing countries themselves have recognised the potential of regenerative medicine and have initiated Research and Development work in this field. We present here the results of a survey of regenerative medicine activities in developing countries, and argue that domestic Science and Technology capacity building and innovation in regenerative medicine can help developing countries to harness its benefits towards low-cost solutions for some of their most pressing health needs.

[1]  G. Rabinovich,et al.  Recombinant Galectin-1 and Its Genetic Delivery Suppress Collagen-Induced Arthritis via T Cell Apoptosis , 1999, The Journal of experimental medicine.

[2]  T. Raj.  The Fortune at the Bottom of the Pyramid: Eradicating Poverty through Profits , 2007 .

[3]  R. Feachem.  Commission on Macroeconomics and Health. , 2002, Bulletin of the World Health Organization.

[4]  L. Vaccarezza.  The new production of knowledge. The dinamics of science and research in contemporary societies, Michael Gibbons, Camille Limoges, Hega Nowotny, Simon Schwartzman, Peter Scott y Martin Trow, Londres, SAGE Publications, 1994, 179 páginas. , 1995 .

[5]  V Mironov,et al.  What is regenerative medicine? Emergence of applied stem cell and developmental biology , 2004, Expert opinion on biological therapy.

[6]  L. Knowles.  A regulatory patchwork—human ES cell research oversight , 2004, Nature Biotechnology.

[7]  Jaideep P. Sundaram,et al.  Health Innovation Networks to Help Developing Countries Address Neglected Diseases , 2005, Science.

[8]  H. Pilcher.  Bone marrow stem cells help mend broken hearts , 2004 .

[9]  D. Balasubramanian,et al.  Successful Reconstruction of Damaged Ocular Outer Surface in Humans Using Limbal and Conjuctival Stem Cell Culture Methods , 2003, Bioscience reports.

[10]  Calestous Juma,et al.  Innovation : applying knowledge in development , 2005 .

[11]  D. Lavanchy,et al.  Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures , 2004, Journal of viral hepatitis.

[12]  William A. Haseltine,et al.  Regenerative Medicine 2003: An Overview , 2003 .

[13]  Mirzadeh Hamid,et al.  Cartilage Tissue Engineering for Ear as in Rabbit Model with Perforated Polyurethane Prosthesis : In Vivo Assay , 2000 .

[14]  Board on Neuroscience.  Stem cells and the future of regenerative medicine , 2002 .

[15]  Q. Schiermeier,et al.  Religion and science: Studies of faith , 2004, Nature.

[16]  R. Pool,et al.  Commission on Life Sciences , 2001 .

[17]  C. Juma,et al.  Reinventing global health: the role of science, technology, and innovation , 2005, The Lancet.

[18]  Abdesslam Boutayeb,et al.  International Journal for Equity in Health the Burden of Non Communicable Diseases in Developing Countries , 2005 .

[19]  A. Daar,et al.  Conclusions: promoting biotechnology innovation in developing countries , 2004, Nature Biotechnology.

[20]  Sarah Jane Marshall,et al.  Developing countries face double burden of disease. , 2004, Bulletin of the World Health Organization.

[21]  Hossein Baharvand,et al.  The effect of extracellular matrix on embryonic stem cell-derived cardiomyocytes. , 2005, Journal of molecular and cellular cardiology.

[22]  S. Paek,et al.  Patient-specific embryonic stem cells derived from human SCNT blastocysts. , 2005, Science.

[23]  R. Preti.  Bringing safe and effective cell therapies to the bedside , 2005, Nature Biotechnology.

[24]  Ritu Sadana,et al.  Increasing International Gaps in Health-Related Publications , 2005, Science.

[25]  Hepeng Jia,et al.  China approves first gene therapy , 2004, Nature Biotechnology.

[26]  L. Fingerhut,et al.  Addressing the growing burden of trauma and injury in low- and middle-income countries. , 2005, American journal of public health.

[27]  C. K. Prahalad,et al.  Fortune at the bottom of the pyramid, the: eradicating poverty through profits , 2006 .

[28]  Vikram Patel,et al.  Under-representation of developing countries in the research literature: ethical issues arising from a survey of five leading medical journals , 2004, BMC medical ethics.

[29]  B. Knoppers,et al.  Legal and Ethical Approaches to Stem Cell and Cloning Research: A Comparative Analysis of Policies in Latin America, Asia, and Africa , 2004, Journal of Law, Medicine & Ethics.